Resources

AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.

To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database

Results

showing 1-10 of 44

Lenacapavir: The case for investing in delivering HIV prevention

The promise of long-acting PrEP has been super-charged this year by studies showing the powerful efficacy of an antiretroviral known as lenacapavir (LEN).

This episode of PxPulse goes deep on LEN for PrEP. Recorded just days before Gilead’s announcement that PURPOSE 2 also found very high efficacy, Dr. Flavia Kiweewa, a principal investigator of PURPOSE 1, the first trial to announce efficacy, lays out the research findings and what they mean.

Prevention Option:

September 2024


PxPulse: An Advocacy Chronicle on U=U in South Africa with Mandisa Dukashe

Mandisa Tyadi Dukashe, Treatment Technical Lead at the South African National AIDS Council (SANAC) describes her work in helping to inspire and launch a National U=U Campaign in South Africa in 2024.

Prevention Option:

August 2024


PxPulse: The Advocacy Chronicles with Ruth Akulu

In this episode, we explore advocacy efforts in Uganda for the Dual Prevention Pill (DPP), a new product that combines oral PrEP and contraception. Discover why the DPP is essential for young women and HIV prevention, and learn about the challenges faced in promoting its use.

July 2024


PxPulse: The Advocacy Chronicles with SMUG’s Allan Mwasa

In this episode, we’re speaking with Nsubuga Allan Mwasa, a Ugandan activist, clinical psychologist and an advocate for mental health and LGBTQ+ rights. Allan serves as Strategic Initiatives Manager at Sexual Minorities Uganda (SMUG), which has been at the forefront of the fight for LGBTQ rights.

Prevention Option:

June 2024


An HIV Vaccine: Looking into the Future with Nina Russell 

In this episode of PxPulse, Dr. Nina Russell, Director of TB & HIV Research and Development for the Bill and Melinda Gates foundation, talks about where she sees promise in the science, the goals for an HIV vaccine, and why it has an essential role to play, alongside the scale up of PrEP.

Prevention Option:

May 2024


PxPulse: The Advocacy Chronicles with APHA’s Yvette Raphael 

Our debut episode of the Advocacy Chronicles features Yvette Raphael, the Executive Director of Advocacy for Prevention of HIV and AIDS (APHA) in South Africa, and a leader in the development of The Choice Manifesto.

April 2024


Decolonizing Global Health: Dr. Madhukar Pai and COMPASS Africa Tell Us Why and How

In this episode of PxPulse, we talk about why and how the decisions that shape global health must be made by those facing the greatest risks. As the world evaluates the pandemic response and debates on decolonizing global health gain momentum, equity in global health has never been more urgent.

March 2024


Inclusion of Pregnant and Lactating People in HIV Research

Produced and hosted by Jeanne Baron People who are pregnant or lactating (PLP) have historically been excluded from research because of concerns for the developing fetus. But this has led to a dearth of data on new interventions against health...

November 2023


PEPFAR at 20: Keeping the promise

2023 is a big year for PEPFAR. Considered one of the greatest US foreign policy and global development achievements of the century, the program has saved upwards of 25 million lives since it launched in 2003. But PEPFAR is marking its 20th anniversary while fighting for its future.

September 2023


Evolving Strategies for an HIV Vaccine: One researcher explains where the field is going and why?

Produced and hosted by Jeanne Baron With several large HIV vaccine trials in the last few years finding no efficacy, the field is in transition. There are diverse ideas in vaccine research, but there’s no clear concept that’s ready to...

Prevention Option:

May 2023


showing 1-10 of 44